Accelerate Targeted Protein Degradation Drug Discovery with Axcelead’s Integrated Platform, DegLead
Axcelead Drug Discovery Partners, Inc.
Accelerate Targeted Protein Degradation Drug Discovery with Axcelead’s Integrated Platform, DegLead
17:39
Identify Promising Novel Leads: Integrated HTS platform powered by computational chemistry and AI/ML
Axcelead Drug Discovery Partners, Inc.
Identify Promising Novel Leads: Integrated HTS platform powered by computational chemistry and AI/ML
18:18
Discovery Platform of Molecular Glue Degrader (MGD)
Axcelead Drug Discovery Partners, Inc.
Discovery Platform of Molecular Glue Degrader (MGD)
1:17
High-throughput Bifunctional Degrader Discovery
Axcelead Drug Discovery Partners, Inc.
High-throughput Bifunctional Degrader Discovery
1:11
Accelerating Bifunctional Degrader Discovery by DegLead
Axcelead Drug Discovery Partners, Inc.
Accelerating Bifunctional Degrader Discovery by DegLead
0:36
Axcelead Platform for TPD ーDegLead
Axcelead Drug Discovery Partners, Inc.
Axcelead Platform for TPD ーDegLead
1:02
Accelerate and achieve an optimal IND for your project～Smart-IND®～
Axcelead Drug Discovery Partners, Inc.
Accelerate and achieve an optimal IND for your project～Smart-IND®～
17:34
The path to success through co-creative medicinal chemistry and drug discovery
Axcelead Drug Discovery Partners, Inc.
The path to success through co-creative medicinal chemistry and drug discovery
23:35
In vitro safety screening in early drug discovery
Axcelead Drug Discovery Partners, Inc.
In vitro safety screening in early drug discovery
21:23
Target identification and validation for drug targets across different therapeutic areas
Axcelead Drug Discovery Partners, Inc.
Target identification and validation for drug targets across different therapeutic areas
21:08
Key success factors for drug discovery
Axcelead Drug Discovery Partners, Inc.
Key success factors for drug discovery
25:56
The importance of PK/PD strategy in drug discovery research
Axcelead Drug Discovery Partners, Inc.
The importance of PK/PD strategy in drug discovery research
17:34
How to proceed GLP toxicity study without cynomolgus monkeys
Axcelead Drug Discovery Partners, Inc.
How to proceed GLP toxicity study without cynomolgus monkeys
37:18
Dsicovery of Selective Inhibitors for 123 Kinases:Kinase Inhibitor Discovery Platform
Axcelead Drug Discovery Partners, Inc.
Dsicovery of Selective Inhibitors for 123 Kinases:Kinase Inhibitor Discovery Platform
4:23
Jump Start Kinase Drug Discovery using A-SKIP
Axcelead Drug Discovery Partners, Inc.
Jump Start Kinase Drug Discovery using A-SKIP
0:47
Mini Kinase Panel 46 selected by AI-analysis
Axcelead Drug Discovery Partners, Inc.
Mini Kinase Panel 46 selected by AI-analysis
1:11
Seamless integration of biology and medicinal chemistry​
Axcelead Drug Discovery Partners, Inc.
Seamless integration of biology and medicinal chemistry​
1:15
Axcelead drives your phenotypic drug discovery
Axcelead Drug Discovery Partners, Inc.
Axcelead drives your phenotypic drug discovery
1:10
Harnessing AS-MS and RapidFire-MS Technologies for Efficient Hit Identification
Axcelead Drug Discovery Partners, Inc.
Harnessing AS-MS and RapidFire-MS Technologies for Efficient Hit Identification
1:22
Axcelead guides your drug discovery
Axcelead Drug Discovery Partners, Inc.
Axcelead guides your drug discovery
0:48
Axcelead guides your drug discovery
Axcelead Drug Discovery Partners, Inc.
Axcelead guides your drug discovery
0:51
Accessing a Diverse and High-Quality Compound Library
Axcelead Drug Discovery Partners, Inc.
Accessing a Diverse and High-Quality Compound Library
0:52
Success Factors for Drug Discovery Journey From the Ground Up
Axcelead Drug Discovery Partners, Inc.
Success Factors for Drug Discovery Journey From the Ground Up
0:48
Integrated Plattform for Hit Identification　～Hit characterization in Post HTS～
Axcelead Drug Discovery Partners, Inc.
Integrated Plattform for Hit Identification　～Hit characterization in Post HTS～
1:13
Integrated Platform for Hit Identification　～Hit expansion in Post HTS～
Axcelead Drug Discovery Partners, Inc.
Integrated Platform for Hit Identification　～Hit expansion in Post HTS～
0:51
Integrated Platform for Hit Identification　～Phenotypic Drug Discovery～
Axcelead Drug Discovery Partners, Inc.
Integrated Platform for Hit Identification　～Phenotypic Drug Discovery～
1:23
Integrated Platform for Hit Identification　～Ion Channel Drug Discovery～
Axcelead Drug Discovery Partners, Inc.
Integrated Platform for Hit Identification　～Ion Channel Drug Discovery～
1:05
Integrated Platform for Hit Identification　～Assay Development～
Axcelead Drug Discovery Partners, Inc.
Integrated Platform for Hit Identification　～Assay Development～
1:10
Improving Drug Discovery with HT-MS
Axcelead Drug Discovery Partners, Inc.
Improving Drug Discovery with HT-MS
1:41
Affinity Selection-Mass Spectrometry (HT-ASMS)
Axcelead Drug Discovery Partners, Inc.
Affinity Selection-Mass Spectrometry (HT-ASMS)
1:12
High Throughput Screening System
Axcelead Drug Discovery Partners, Inc.
High Throughput Screening System
0:35
Hit rates (＞90%) in HTS campaigns is very high. Do you know why Axcelead HTS has been successful?
Axcelead Drug Discovery Partners, Inc.
Hit rates (＞90%) in HTS campaigns is very high. Do you know why Axcelead HTS has been successful?
0:53
Aim for high-quality hit compounds with over 1.5 million diverse compound library
Axcelead Drug Discovery Partners, Inc.
Aim for high-quality hit compounds with over 1.5 million diverse compound library
0:35
Axcelead Pitch Presentation at Japan Innovation Night during BIO International Convention 2023
Axcelead Drug Discovery Partners, Inc.
Axcelead Pitch Presentation at Japan Innovation Night during BIO International Convention 2023
2:09
Rapid Discovery! Accelerate drug discovery from hit id to clinic
Axcelead Drug Discovery Partners, Inc.
Rapid Discovery! Accelerate drug discovery from hit id to clinic
59:08
SMART-IND：Tailored IND-enabling package service to client goal
Axcelead Drug Discovery Partners, Inc.
SMART-IND：Tailored IND-enabling package service to client goal
6:47
Dr. Hideo Fukui will chair the international symposium at the American College of Toxicology 2022!
Axcelead Drug Discovery Partners, Inc.
Dr. Hideo Fukui will chair the international symposium at the American College of Toxicology 2022!
1:39
Driving innovative drug discovery through integrated high-throughput screening platform
Axcelead Drug Discovery Partners, Inc.
Driving innovative drug discovery through integrated high-throughput screening platform
31:25
Axcelead, the first integrated drug discovery solutions provider in Japan.
Axcelead Drug Discovery Partners, Inc.
Axcelead, the first integrated drug discovery solutions provider in Japan.
5:36
Phenotypic Drug Discovery Platform
Axcelead Drug Discovery Partners, Inc.
Phenotypic Drug Discovery Platform
8:21
High-throughput mass spectrometry for hit identification
Axcelead Drug Discovery Partners, Inc.
High-throughput mass spectrometry for hit identification
7:40
Integrated HTS platform for innovative drug discovery
Axcelead Drug Discovery Partners, Inc.
Integrated HTS platform for innovative drug discovery
8:46